Dr. Matthew D. Truesdale, MD

Dr. Truesdale practices at Advanced Urology Institute in Oxford, Florida.

Dr. Truesdale's NPI, 1336439702, was assigned on April 19, 2011. Dr. Truesdale graduated from Vagelos College of Physicians and Surgeons in 2011. Dr. Truesdale holds Florida license ME132740.

Dr. Truesdale's primary practice is Advanced Urology Institute, at 12109 County Rd 103, Oxford, FL 34484 in Sumter County. The practice phone is (352) 391-6494.

Dr. Truesdale's primary practice is Advanced Urology Institute in Oxford, Florida. Dr. Truesdale is also affiliated with BayCare St. Joseph's Hospital. The medical group on file is Advanced Urology Institute. Dmand AI also links Dr. Truesdale to 2 more hospitals, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Truesdale practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Truesdale's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Truesdale is board certified in urology by the American Board of Urology. Dmand AI has Dr. Truesdale's licenses on file in 2 states: Florida and California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and pelvic prolapse among the conditions Dr. Truesdale treats.

CMS data shows 6,677 Medicare services from Dr. Truesdale across 42 procedure codes in 2024, for 1,107 Medicare patients. Medicare paid $366,590 for them.

CMS counts 1,107 Medicare patients who saw Dr. Truesdale in 2024. The largest group is 65 to 74, with 487 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Truesdale's median patient age at 70, with 25% women.

In 2024, Dr. Truesdale wrote 4,599 Medicare Part D claims for 1,055 patients. 80% of them were for generic drugs. CMS names the drug for 4,490 of them, across 41 drugs with 11 or more claims each, at $4,459,573 in total drug cost. In 2023, CMS named 3,619 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Truesdale for performance year 2024, reported as part of a group. Dr. Truesdale accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Truesdale as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 22 papers to Dr. Truesdale, published from 2010 to 2017. 2011 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Cryosurgery. Dr. Truesdale has published most often in J Endourol. Dr. Truesdale's most frequent co-authors are Jaime Landman, MD, Ketan K. Badani, MD and Mohannad A. Awad.

CMS Open Payments shows 362 general payments to Dr. Truesdale from 56 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Janssen Pharmaceuticals, Inc paid the most, $9,204.

Dmand AI lists 1 award for Dr. Truesdale.

Dr. Truesdale graduated from Vagelos College of Physicians and Surgeons in 2011. Dr. Truesdale is a member of ACS.

Dr. Truesdale is in network with 12 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.